These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24089567)

  • 21. Herpesvirus seropositivity in childhood associates with decreased monocyte-induced NK cell IFN-gamma production.
    Saghafian-Hedengren S; Sundström Y; Sohlberg E; Nilsson C; Linde A; Troye-Blomberg M; Berg L; Sverremark-Ekström E
    J Immunol; 2009 Feb; 182(4):2511-7. PubMed ID: 19201907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection.
    Tsuge I; Morishima T; Kimura H; Kuzushima K; Matsuoka H
    J Med Virol; 2001 Jun; 64(2):141-8. PubMed ID: 11360246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence.
    Heath J; Newhook N; Comeau E; Gallant M; Fudge N; Grant M
    J Immunol Res; 2016; 2016():7470124. PubMed ID: 27314055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asymptomatic CMV Replication During Early Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower CD4/CD8 Ratio During HIV Treatment.
    Smith DM; Nakazawa M; Freeman ML; Anderson CM; Oliveira MF; Little SJ; Gianella S
    Clin Infect Dis; 2016 Dec; 63(11):1517-1524. PubMed ID: 27601222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Replication of Human Herpesviruses Is Associated with Higher HIV DNA Levels during Antiretroviral Therapy Started at Early Phases of HIV Infection.
    Gianella S; Anderson CM; Var SR; Oliveira MF; Lada SM; Vargas MV; Massanella M; Little SJ; Richman DD; Strain MC; Pérez-Santiago J; Smith DM
    J Virol; 2016 Apr; 90(8):3944-3952. PubMed ID: 26842469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia.
    Giménez E; Solano C; Amat P; de la Cámara R; Nieto J; López J; Garcia-Noblejas A; Navarro D
    J Med Virol; 2015 Sep; 87(9):1601-7. PubMed ID: 25802229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.
    deBruyn JCC; Soon IS; Fonseca K; Feng S; Purtzki M; Goedhart C; Kuhn S; Vanderkooi OG; Wrobel I
    Inflamm Bowel Dis; 2019 Jun; 25(7):1218-1226. PubMed ID: 30551205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strong response of T cells in infants with dual infection by Epstein-Barr virus and cytomegalovirus.
    Wakiguchi H; Hisakawa H; Kubota H; Kurashige T
    Pediatr Int; 1999 Oct; 41(5):484-9. PubMed ID: 10530058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NKG2C
    Grutza R; Moskorz W; Senff T; Bäcker E; Lindemann M; Zimmermann A; Uhrberg M; Lang PA; Timm J; Cosmovici C
    J Immunol; 2020 Jun; 204(11):2910-2917. PubMed ID: 32284334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanding cytotoxic T lymphocytes from umbilical cord blood that target cytomegalovirus, Epstein-Barr virus, and adenovirus.
    Hanley PJ; Lam S; Shpall EJ; Bollard CM
    J Vis Exp; 2012 May; (63):e3627. PubMed ID: 22588077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of CMV and EBV on Immune Recovery After Allogeneic Hematopoietic Cell Transplantation in Children.
    Pukownik E; Kubicka M; Kurylo-Rafinska B; Debski R; Galazka P; Czyzewski K; Krenska A; Bartoszewicz N; Demidowicz E; Marjańska A; Dziedzic M; Pogorzala M; Wysocki M; Styczynski J
    Anticancer Res; 2018 Oct; 38(10):6009-6013. PubMed ID: 30275233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2C
    Comeau EM; Holder KA; Fudge NJ; Grant MD
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30857329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Frequency of CMV Replication and Disease Complications Reveals New Cellular Defects and a Time Dependent Pattern in CVID Patients.
    Marri L; Contini P; Ivaldi F; Schiavi C; Magnani O; Vassallo C; Guastalla A; Traversone N; Angelini C; Del Zotto G; De Maria A; De Palma R
    J Clin Immunol; 2024 Jun; 44(6):142. PubMed ID: 38847943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human cytomegalovirus and Epstein-Barr virus infections, risk factors, and their influence on the liver function of patients with acute-on-chronic liver failure.
    Hu J; Zhao H; Lou D; Gao H; Yang M; Zhang X; Jia H; Li L
    BMC Infect Dis; 2018 Nov; 18(1):577. PubMed ID: 30445927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coinfection rates and clinical outcome data for cytomegalovirus and Epstein-Barr virus in post-transplant patients: A systematic review of the literature.
    Anderson-Smits C; Baker ER; Hirji I
    Transpl Infect Dis; 2020 Dec; 22(6):e13396. PubMed ID: 32603496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of immunoglobulins and natural killer cells in the context of CMV and EBV infection.
    Frenzel K; Lehmann J; Krüger DH; Martin-Parras L; Uharek L; Hofmann J
    Med Microbiol Immunol; 2014 Apr; 203(2):115-23. PubMed ID: 24337366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late Development of FcεRγ
    Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
    Front Immunol; 2018; 9():1050. PubMed ID: 29868012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ex vivo generation of effective Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocytes from the peripheral blood of immunocompetent Epstein Barr virus-seronegative individuals.
    Metes D; Storkus W; Zeevi A; Patterson K; Logar A; Rowe D; Nalesnik MA; Fung JJ; Rao AS
    Transplantation; 2000 Nov; 70(10):1507-15. PubMed ID: 11118098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salivary shedding of Epstein-Barr virus and cytomegalovirus in people infected or not by human immunodeficiency virus 1.
    de França TR; de Albuquerque Tavares Carvalho A; Gomes VB; Gueiros LA; Porter SR; Leao JC
    Clin Oral Investig; 2012 Apr; 16(2):659-64. PubMed ID: 22186943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men.
    Scaggiante R; Andreis S; Basso M; Franchin E; Franzetti M; Del Vecchio C; Torti C; Mengoli C; Cruciani M; Sarmati L; Palù G; Parisi SG
    J Med Virol; 2016 Jul; 88(7):1211-21. PubMed ID: 26636290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.